Cormedix Inc (NAS:CRMD)
$ 8.405 0.075 (0.9%) Market Cap: 505.44 Mil Enterprise Value: 459.97 Mil PE Ratio: 0 PB Ratio: 8.25 GF Score: 35/100

CorMedix Inc Annual Shareholders Meeting Transcript

Dec 09, 2021 / 02:00PM GMT
Release Date Price: $4.97 (-2.93%)
Operator

Good day and welcome to the CorMedix Inc. 2021 Annual Meeting of Stockholders. I would now like to turn the conference over to Matt David, Interim Chief Executive Officer and Chief Financial Officer of CorMedix Inc. Please go ahead.

Matthew T. David;Phoebe Mounts
CorMedix Inc. - Interim CEO, Executive VP & CFO;CorMedix Inc. - Executive VP, General Counsel,

Thank you. Good morning. I am Matt David, Interim CEO and Chief Financial Officer of CorMedix. It is a pleasure to welcome you to our 2021 Annual Meeting of Stockholders, which is being held virtually as a result of the pandemic. This meeting is now called to order.

Before we begin, I would like to introduce the company's officers who are with us today, including Dr. Phoebe Mounts, CorMedix' EVP and General Counsel; and Tom Nusbickel, EVP and Chief Commercial Officer. I would like to extend a welcome to our Board members who are also joining us today.

I would now like to turn the meeting over to Phoebe Mounts to handle procedural matters. Phoebe?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot